The global MRI contrast agent market is anticipated to grow at a considerable CAGR of 4.2% during the forecast period. The rising frequency of chronic diseases affecting the brain, spine, and liver, as well as the occurrence of joint injuries in developing nations, however, the cost of MRI diagnostic is prohibitive, limiting the use of MRI techniques for diagnosis. As a result, the market’s expansion may be slowed. The cost of MRI contrast agents is reasonable, however, the cost of an MRI scan is relatively high. Patients and clinicians alike are hesitant to use MRI for disease diagnosis as a result of this. For instance, In November 2020, Siemens Healthineers has presented a new class of magnetic resonance imaging (MRI) systems that the company named “High-V MRI.” The scanner’s unique combination of digital technologies and the new field strength of 0.55 tesla broadens the range of clinical applications for MRI systems. Magnetom Free. Max considerably improves pulmonary imaging with MRI and allows patients with implants to be scanned much more accurately. Siemens Healthineers has also enlarged the bore size to 80 cm, making the experience more comfortable for patients.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/mri-contrast-media-market
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Product Type
- By Indication
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- including Bayer AG, Bracco Imaging S.p.A, GE Healthcare, iMax Diagnostic Imaging Ltd., Nano Therapeutics Pvt. Ltd. and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global MRI Contrast Agent Market Report Segment
By Product Type
- Iodinated
- Gadolinium
- Barium
- Microbubble
By Indication
- Cardiovascular
- Neurological
- Oncology
- Gastrointestinal
- Others
A full report of MRI Contrast Agent Market is available at: https://www.omrglobal.com/industry-reports/mri-contrast-media-market
MRI Contrast Agent Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Acro Lifesciences Pvt. Ltd.
- Beijing Beilu Pharmaceutical Co., Ltd.
- Guerbet
- B. Chemicals and Pharmaceuticals Ltd.
- Jodas Expoim
- Kiran X-ray Pvt. Ltd.
- Lantheus Medical Imaging, Inc.
- Livealth Biopharma Pvt. Ltd.
- Rege Imaging & Cine Film Pvt. Ltd.
- SANOCHEMIA Pharamazeutica GmbH
- Subhra Pharma Pvt. Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
